Intentional extreme anisometropic pseudophakic monovision: new approach to the cataract patient with longstanding diplopia.
OBJECTIVE
To determine whether extreme pseudophakic monovision can reduce or eliminate diplopia in patients with cataract and longstanding acquired strabismus.


METHODS
Department of Ophthalmology, University of Cincinnati, and the Cincinnati Eye Institute, Cincinnati, Ohio, USA.


METHODS
Case series.


METHODS
Intentional extreme monovision was created in patients with stable diplopia having cataract surgery. Intraocular lens selection was targeted for emmetropia in 1 eye and at least 3.0 diopters of myopia in the fellow eye.


RESULTS
Twelve patients with stable diplopia attained excellent uncorrected distance and near vision with a marked reduction in or elimination of double vision.


CONCLUSIONS
Patients with stable acquired strabismus with diplopia may be candidates for extreme pseudophakic monovision, which may be a new strategy to eliminate double vision.


BACKGROUND
No author has a financial or proprietary interest in any material or method mentioned.
Cincinnati Eye Institute, Cincinnati, Ohio 45242, USA. rhosher@cincinnatieye.com
Robert H
RH
Osher
Karl C
KC
Golnik
Graham
G
Barrett
Kimiya
K
Shimizu
D000368:Aged; D000369:Aged, 80 and over; D015858:Anisometropia / Q000209:etiology* / Q000503:physiopathology; D002386:Cataract / Q000628:therapy; D003867:Depth Perception / Q000502:physiology; D004172:Diplopia / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D019591:Pseudophakia / Q000209:etiology* / Q000503:physiopathology; D013285:Strabismus / Q000503:physiopathology / Q000628:therapy; D014792:Visual Acuity / Q000502:physiology